PharmGen Science, Inc. (KRX:004720)
South Korea · Delayed Price · Currency is KRW 3,835.00
+25.00 (0.66%)
At close: Nov 25, 2025
PharmGen Science Market Cap
PharmGen Science has a market cap or net worth of 73.51 billion as of November 26, 2025. Its market cap has decreased by -15.21% in one year.
Market Cap
73.51B
Enterprise Value
78.86B
Revenue
171.66B
Ranking
n/a
PE Ratio
624.28
Stock Price
3,835.00
Market Cap Chart
Since August 31, 1995, PharmGen Science's market cap has increased from 10.89B to 73.51B, an increase of 574.90%. That is a compound annual growth rate of 6.51%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 26, 2025 | 73.51B | -0.90% |
| Dec 30, 2024 | 74.18B | -33.39% |
| Dec 28, 2023 | 111.36B | 5.58% |
| Dec 29, 2022 | 105.47B | -33.88% |
| Dec 30, 2021 | 159.51B | -3.78% |
| Dec 30, 2020 | 165.78B | 123.51% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 75.32T |
| Celltrion | 39.93T |
| ALTEOGEN | 27.70T |
| SK Biopharmaceuticals | 10.10T |
| ABL Bio | 9.15T |
| Yuhan | 8.55T |
| Peptron | 7.43T |
| LigaChem Biosciences | 6.30T |